Ranolazin: mechanism of antianginal effects


Ozdemir M.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, cilt.44, ss.8-12, 2016 (ESCI İndekslerine Giren Dergi) identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 44
  • Basım Tarihi: 2016
  • Doi Numarası: 10.5543/tkda.2016.72626
  • Dergi Adı: TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
  • Sayfa Sayıları: ss.8-12

Özet

Ranolazin is indicated for the control of angina in patients with chronic stable coronary artery disease. Born as a "metabolic modulator", ranolazine is now considered to be a "late sodium current blocker". This review tries to summarize the mechanism of antianginal effects of ranolazine.